FOR IMMEDIATE RELEASE
Integration Links Premier Data Integration and Analysis Solution withLeading Electronic Clinical Data Management Solution
ATLANTA (June 18, 2007) – SAS, the leader in business intelligence, and Medidata Solutions, a global provider of electronic clinical data capture,
management and reporting solutions, today announced the integration of Medidata Rave®, the industry-leading system for capturing, managing and reporting clinical research data, with SAS® Drug Development, SAS’ powerful data management, collaborative reporting and analysis solution for pharmaceutical, medical device and biotechnology firms.
“The life science industry is undergoing a dramatic transformation, a transformation driven by the availability of real-time clinical data,” said Chris Connor, Senior Research Analyst at Health Industry Insights, an IDC company. “When the operational and clinical data management features found in Medidata Rave are combined with the analytics and data integrity features available in SAS Drug Development, the industry has the first example of a next-generation platform capable of supporting the transactional requirements of adaptive trials and ultimately personalized medicine.”
Traditionally, sponsors have collected clinical trial data using paper-based systems. At the end of the study, researchers would bring all the clinical data together in a standalone clinical data management system for reconciliation and cleaning, and then transfer the data into an analysis environment for decision-making.
Through this integration available to customers worldwide, data collected and managed in Medidata Rave will be immediately accessible through SAS Drug Development, along with other data gathered in the research and development process. Sponsors benefit from streamlined access to study data on one uniform, regulatory-compliant data management path. As a result, clinicians will be able to experience improved accuracy and efficiency in data collection, management and regulatory compliance.
“This integration offers customers an opportunity to revolutionize clinical development by speeding data transparency from patient to p-value,” said Jason Burke, Worldwide Director of the SAS Health and Life Sciences Global Practice. “In doing so, SAS and Medidata can further push legacy clinical data management systems (CDMS) toward obsolescence.”
Sponsors are looking to streamline their end-to-end clinical research processes, which have been supported by standalone, independent systems. The maintenance of a large number of integrations, however, has limited their ability to cost-effectively deploy systems that support faster decision-making.
“Medidata Rave and SAS Drug Development represent two halves of the end-to-end decision-making process,” said Glen de Vries, CTO of Medidata Solutions. “Sponsors will benefit from a seamless flow of data in a secure and regulatory-compliant environment.”
Both companies will be exhibiting at the Drug Information Association’s (DIA) 43rd Annual Meeting, June 17–21, 2007 in Atlanta. To learn more about this integration, please visit SAS in booth #215 and Medidata in booth #1327.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology, medical device and research organizations maximize the value of their clinical research investments. Innovative process design, technology and services streamline clinical trials by providing early visibility to reliable clinical data—the lifeblood of every research organization. Working with companies and institutions both large and small, Medidata Solutions helps clinical researchers safely accelerate the process of bringing life-enhancing treatments to market—on six continents and in more than 80 countries. Medidata Solutions brings significant value to its broad client base with deep clinical experience and expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. For more information, please visit www.mdsol.com.
About SAS
SAS is the leader in business intelligence and analytical software and
services. Customers at 43,000 sites use SAS software to improve
performance through insight from data, resulting in faster, more accurate
business decisions; more profitable relationships with customers and
suppliers; compliance with governmental regulations; research breakthroughs;
and better products and processes. Only SAS offers leading data integration,
storage, analytics and business intelligence applications within a
comprehensive enterprise intelligence platform. Since 1976, SAS has been
giving customers around the world THE POWER TO KNOW®. www.sas.com
SAS and all other SAS Institute Inc. product or service names are registered trademarks or
trademarks of SAS Institute Inc. in the USA and other countries. ® indicates USA registration.
Other brand and product names are trademarks of their respective companies. Copyright © 2007
SAS Institute Inc. All rights reserved.
Contacts:
Bob Chase
SAS
919.531.4327
bob.chase@sas.com
Visit the SAS Press Center
www.sas.com/presscenter
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com